News
FDA officials have warned the American public to not eat, sell or serve cucumbers grown and distributed by two Florida ...
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Explore more
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...
In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...
Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results